Funding Rounds
MIP Discovery

MIP Discovery Series A (2024, $8M)

MIP Discovery

Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $8.83M

Investors